Hot Topics in Neurological Disorder Therapeutics and Technologies

June 22, 2021

[ Click here to view recording ]


  • Lauren Martz, Senior Editor, Head, Translation and Clinical Development, BioCentury Inc.


  • Sarah Bhagat, PhD, General Partner, Sofinnova Investments
  • Ginger S. Johnson, PhD, Chief Executive Officer, Cello Health BioConsulting
  • Norbert Riedel, PhD, Chief Executive Officer, Aptinyx Inc.
  • Myung Shin, PhD, Executive Director and Head of Early Discovery Genetics, Genetics and Pharmacogenomics, Merck & Co., Inc.